Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

HIGHLINE LABS, LLC

NPI: 1639541295 · CHARLOTTE, NC 28269 · Clinical Medical Laboratory · NPI assigned 10/22/2015

$5.72M
Total Medicaid Paid
237,630
Total Claims
192,077
Beneficiaries
101
Codes Billed
2018-01
First Month
2020-06
Last Month

Provider Details

Authorized OfficialDIENST, RYAN (CEO)
NPI Enumeration Date10/22/2015

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 93,519 $2.31M
2019 129,873 $3.00M
2020 14,238 $420K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 40,410 31,471 $1.23M
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 16,114 12,861 $1.05M
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 10,129 8,318 $716K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 7,276 6,027 $438K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 4,597 2,458 $206K
81226 1,537 1,389 $127K
81225 1,522 1,371 $83K
80346 6,118 5,194 $80K
80361 6,152 5,217 $79K
80348 6,133 5,193 $78K
80356 6,056 5,133 $78K
80365 6,150 5,215 $77K
80353 6,319 5,149 $76K
80354 5,988 5,059 $76K
80359 5,836 4,979 $74K
80325 5,802 4,928 $72K
83992 5,187 4,453 $72K
80373 5,602 4,755 $69K
80358 5,304 4,460 $68K
80360 5,296 4,624 $65K
80372 5,311 4,623 $65K
80363 4,195 3,461 $53K
81227 1,524 1,373 $51K
80349 4,238 3,628 $50K
80345 3,215 2,711 $39K
81401 1,828 1,207 $32K
80357 2,333 2,109 $31K
80323 2,127 1,932 $31K
80370 1,807 1,634 $28K
81241 1,418 1,288 $26K
80320 2,002 1,780 $25K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,309 1,240 $25K
80355 2,618 2,296 $25K
80366 2,558 2,242 $24K
80364 1,834 1,660 $23K
81328 1,007 916 $23K
81240 1,418 1,288 $22K
81230 1,094 997 $20K
81231 1,090 993 $20K
80050 General health panel 559 539 $18K
81291 1,415 1,284 $17K
81355 1,311 1,189 $15K
84481 1,214 1,131 $14K
80061 Lipid panel 1,536 1,437 $14K
84403 730 674 $13K
82607 1,176 1,111 $12K
82670 577 540 $12K
84443 Thyroid stimulating hormone (TSH) 995 924 $11K
82627 621 583 $11K
86376 1,037 951 $10K
80053 Comprehensive metabolic panel 1,510 1,402 $10K
83970 340 313 $9K
83036 Hemoglobin; glycosylated (A1C) 1,265 1,196 $8K
82728 752 729 $8K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 55 45 $7K
84270 540 492 $7K
84439 1,190 1,104 $7K
84144 522 482 $7K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,230 1,159 $6K
82172 382 170 $5K
83001 510 477 $5K
81400 226 205 $5K
82533 404 375 $5K
82746 440 422 $5K
83002 481 451 $4K
84681 224 223 $4K
83735 826 790 $4K
83003 361 333 $4K
83090 280 259 $4K
83550 576 535 $3K
86141 240 237 $3K
83525 265 261 $3K
84146 203 186 $3K
83540 520 474 $2K
83695 274 253 $2K
80368 166 156 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 109 45 $2K
80342 367 326 $1K
84550 468 457 $1K
87486 59 49 $918.19
84153 71 68 $876.06
87581 54 44 $687.37
80367 240 219 $639.17
81479 Unlisted molecular pathology procedure 9,915 1,247 $608.95
82977 77 75 $534.48
86696 19 19 $410.21
80369 19 18 $341.41
86038 132 129 $329.78
81003 145 136 $318.24
86695 19 19 $279.31
86140 45 44 $251.55
APT17 14 14 $186.06
85610 47 45 $171.94
86431 154 145 $171.22
82043 29 24 $110.27
80362 126 123 $88.33
81001 30 26 $67.71
80324 17 17 $60.64
83690 18 18 $54.58
84480 32 29 $46.65
84436 17 17 $8.62